OMX Copenhagen 20
1.737,21
PKT
+1,73
PKT
+0,10
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
20.08.20 | A.P. Moeller - Maersk A-S (B) buy | Deutsche Bank AG | |
20.08.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
19.08.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
18.08.20 | Novo Nordisk Neutral | UBS AG | |
18.08.20 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
14.08.20 | Novo Nordisk Hold | Kepler Cheuvreux | |
11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.08.20 | Novo Nordisk Neutral | UBS AG | |
06.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.08.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
06.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
20.07.20 | Novo Nordisk Neutral | UBS AG | |
16.07.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.07.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
06.07.20 | A.P. Moeller - Maersk A-S (B) buy | Deutsche Bank AG | |
02.07.20 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
22.06.20 | Novo Nordisk Neutral | Oddo BHF | |
19.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
19.06.20 | A.P. Moeller - Maersk A-S (B) neutral | Jefferies & Company Inc. | |
17.06.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
17.06.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.06.20 | Novo Nordisk Neutral | UBS AG | |
01.06.20 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
29.05.20 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
28.05.20 | A.P. Moeller - Maersk A-S (B) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
26.05.20 | A.P. Moeller - Maersk A-S (B) Hold | Jefferies & Company Inc. | |
21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.05.20 | Novo Nordisk Neutral | UBS AG | |
14.05.20 | A.P. Moeller - Maersk A-S (B) buy | HSBC |